Texas House signals expanding state's medical marijuana program
House Bill 46 by Rep. Ken King, R-Canadian, would allow patients in the state's medical marijuana program to use products like cannabis patches, lotions, and prescribed inhalers and vaping devices. The House preliminarily approved the bill 118 to 16 on Monday and will need a final round of approval before it heads to the Senate.
If it becomes law, the list of qualifying conditions would also expand to include chronic pain, traumatic brain injury, Crohn's disease, and degenerative disc disease. The bill would also let licensed dispensers open more satellite locations, which supporters say is necessary to prevent the industry from crumbling.
'There are too many Texans who are still struggling to get access to the medicine they legally have a right to receive,' King said, pointing out his bill would allow for additional dispensing locations outside of Central Texas, where all dispensaries are currently concentrated.
Rep. Penny Morales Shaw, D-Houston, said rural Texans would have more access.
'Too many of our fellow Texans are forced to either suffer or self medicate because they don't have sufficient access, and this is an amazing alternative to addictive, harmful opioids, which we know is a huge problem,' she said.
In Texas, licensed medical cannabis providers must house all operations, including cannabis cultivation, processing, extracting, manufacturing, testing, and dispensing, under one roof.
State regulations also prohibit inventory storage of medical cannabis products in multiple locations, so products must be distributed from the central dispensary. Any prescriptions scheduled for pickup outside the central dispensary must be driven daily to and from the pickup location—sometimes thousands of miles round-trip.
'This method puts wear and tear on our vehicles. Limits the amount of time we can spend with patients and can compromise product integrity,' said Terrence Baugh, marketing manager for goodblend, Austin-based medical marijuana producer. 'We might drive 200 miles, and the person we are delivering to might not even be there at the moment.'
This has made their products more expensive and limited where the medical marijuana program can reach, hampering the small medical cannabis market in Texas.
'We also don't have enough doctors in the program, and not enough people prescribing for it, and most patients find us through a doctor. We are dealing with several different challenges, but we are hopeful these bills might help,' said Baugh.
House Bill 46 is meant to correct some of this problem by allowing medical marijuana distributors to store their products in various satellite locations instead of having to drive across the state to return the product every day.
However, the most significant potential change would be allowing smokable marijuana products, such as vapes, to be introduced into the program, helping to match the popularity of products found in the hemp industry. The Texas medical program can currently only sell gummies, lozenges, topicals, beverages, and tinctures, as smoking or vaping products have not been approved.
Many hemp products, which are unregulated and sold more freely in smoke shops, also give the same high as medical marijuana, but are cheaper for consumers, and don't require a visit to a medical professional for pre-approval to purchase. This ease of access has pretty much made the medical marijuana program irrelevant, according to the medical marijuana industry.
Dillan Dabelsutt, senior manager of cultivation at goodblend, said the only difference between hemp and medical marijuana is that hemp is harvested earlier.
'Hemp is just a little more flexible while marijuana is produced for high THC alone,' he said.
By allowing smokeables and expanding the conditions, the medical marijuana producers are hoping this will open the market up to more patients and increase the demand for products.
Texas lawmakers are also determining the future of hemp this session, as a House panel approved last month a bill, also authored by King, to tighten regulations on Texas' consumable hemp industry, setting up a potential clash with Lt. Gov. Dan Patrick and the Senate, who are pursuing a total ban on THC products.
'I think we can co-exist with hemp. We just want an even playing field,' said Baugh. 'I believe additional regulations are needed on hemp, and we need to loosen some on medical marijuana.'
King noted on Monday that HB 46 would have no effect on hemp and that the future of that industry will be decided another day.
'The other bill will be coming to a House floor near you,' he told lawmakers.
Texans seeking help for substance use can call the Substance Abuse and Mental Health Services Administration's free help line at 800-662-4357. They can also access services in their region through the Texas Health and Human Services website.
First round of TribFest speakers announced! Pulitzer Prize-winning columnist Maureen Dowd; U.S. Rep. Tony Gonzales, R-San Antonio; Fort Worth Mayor Mattie Parker; U.S. Sen. Adam Schiff, D-California; and U.S. Rep. Jasmine Crockett, D-Dallas are taking the stage Nov. 13–15 in Austin. Get your tickets today!
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Upturn
7 hours ago
- Business Upturn
Liquid I.V. Debuts Innovative New Sugar-Free Hydration Multiplier in Canada
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) — Today, Liquid I.V., the number one selling powdered hydration brand in Canada1 announced the expansion of their product portfolio with the launch of the new Sugar-Free Hydration Multiplier. Available in the delicious and refreshing White Peach flavour, this launch marks Liquid I.V.'s most significant innovation in the market to date and is the brand's first sugar-free offering for Canadians. 'Sugar-free marks a bold step forward for Liquid I.V., cementing our place not only as leaders but innovators of hydration solutions,' said Anusha Babbar, Senior Vice President of International, Unilever Wellbeing. 'Canadians have shown great love to Liquid I.V. these past two years in market, so we're thrilled to be expanding our Canadian offering in the wellness category to meet their demands for a sugar-free option.' Liquid I.V. entered Canada in 2023, marking its first expansion beyond the U.S., and quickly established itself as a leading provider of powdered hydration. Yet, fans of the electrolyte beverage have been vocal about the need for a sugar-free option to meet their lifestyle needs. Today, Liquid I.V. responds to the demand with a first-of-its-kind formula that is scientifically formulated to restore electrolyte imbalances that occur through performance, heat, travel and adventure, without the sugar. 'Sugar is often used as a key ingredient in electrolyte beverages for hydration support. We clinically tested countless sugar-free formulations to ensure that we weren't just ticking a box, but creating a formula backed by science that truly supported functional hydration,' said Lori Lauersen, Senior Vice President R&D, Unilever Wellbeing. 'What we developed was an amino acid blend available in our Sugar-Free Hydration Multiplier, all delivered within a delightful peach flavoured beverage.' Liquid I.V. Sugar-Free White Peach Hydration Multiplier delivers smart 0 sugar hydration that supports consumers in maintaining their wellness goals. It contains: 0g sugar 6 essential vitamins and minerals Blend of amino acids No artificial flavours or colours 100% + daily value of essential B vitamins (B3, B5, B12) To enjoy, simply pour one easy-to-open packet into 500ml of water, mix or shake, and hydrate. Its convenient single-serve, travel-friendly packets are easy to enjoy on the go. Liquid I.V. Sugar-Free White Peach is currently available at Costco Canada and will be available on later this month. About Liquid I.V.® Liquid I.V.® is a wellness company based in Los Angeles, CA. We believe hydration is the bedrock of wellness so our products are designed to deliver hydration and additional benefits with delicious flavour. The product line features great-tasting, non-GMO electrolyte drink mixes for enhanced hydration. As a purpose-driven brand, giving back is at the core of Liquid I.V.'s DNA, to date we've donated over 71 million servings to people in need around the globe. Liquid I.V.® contributes over 1% of brand revenue to our Impact Program focused on Clean Water Access & Hydration Aid. Liquid I.V.® provides grants to organizations that expand clean water access. We are committed to our goal of donating 150 million Liquid I.V.® sticks over the next 10 years. Liquid I.V. is available in-store at Costco, Walmart, and other national retailers, and online on To learn more, visit and follow @liquidivcanada on Instagram, TikTok and Facebook. For more information, please contact:Amanda FederchukKetchum, on behalf of Liquid I.V. [email protected] 416-505-0517


Time Business News
7 hours ago
- Time Business News
D-Dimer Test Flags Clot Risk, Aids Broader Diagnosis
D Dimer Test is a kind of blood test detecting the presence of D-dimer in the blood. D-dimer is a protein fragment of fibrin formed after Fibrinolysis degradation of blood clot. It is helpful to diagnose the conditions with abnormal blood clots formation and breakdown, intravascular fibrinolysis, and coagulation. High D-dimer levels indicate clinical suspicion of a blood clot and needs ultrasound, CT angiography, scans could be performed to confirm the presence of clot and location of clot. D-Dimer test is not specific to any disease. D-Dimer test is not specific to any disease and thus is performed in conjunction with other evaluations and diagnostic tests. 0.5 is measured as normal range for D-dimer and greater than 0.5 is measured to be positive. D-dimer decreases under abnormal medical case which is measured by specific antibodies. Key Growth Drivers and Opportunities Demand for D-Dimer Testing: Traditional testing is replaced by D-dimer testing, allowing for faster test results, quicker diagnosis, shorter patient wait times, and better patient outcomes overall. D-Dimer testing to be more widely used by customers offering compelling advantages. Moreover, the growing prevalence of lung and cardiovascular illnesses might, in extreme circumstances, lead to potentially fatal blood clot problems, which propels D-Dimer Test. Rising Genetic Disorders: Increasing cases of Thrombus embolism along with various cardiovascular and pulmonary diseases that could be life threating due to clot formation increases the demand for D-Dimer Test globally. D-dimer functions as valuable marker in various clinical conditions such as HIV, atrial fibrillation, coronary artery disease. New technological advancement such as development of aptamers, reducing use of antibodies for D-dimer testing being cost-effective, long-lasting boosts D-Dimer Test widening scope for these tests. Challenges The major challenge consists of inadequate skilled professionals and trained professionals unable to perform the test properly and lack of knowledge leads to false results and restrains the D-Dimer test Market. High cost and poor reimbursement policies restrains people to take such tests for proper diagnosis increasing the prevalence of disease and deaths. Innovation and Expansion Study Links Long COVID Brain Fog to Blood Microclots In September 2023, Finding was published in Nature Medicine, suggesting links between brain fog in long COVID and 'micro clots' in the blood. These clots often contain misfolded fibrinogen proteins that prevent the clots from breaking down, and this effect can clog blood vessels and block oxygen flow to the brain and other organs. Blood tests for both D-dimer and fibrinogen are already standard around the world, so researchers had plenty of available data to check whether the same phenomenon occurred in other groups of patients. LumiraDx Expands Rapid Testing for VTE and Heart Failure In June 2022, LumiraDx Limited, a next-generation point of care Diagnostics Company, announced its cardiovascular offering with a CE Mark for its new NT-proBNP test to aid in the diagnosis of CHF and an updated CE Mark for its D-Dimer test to now rule out venous thromboembolism (VTE) in symptomatic patients. With these two additions, the LumiraDx Platform can further support clinicians in quickly and accurately assessing patient symptoms for both VTE and heart failure at the point of care. The LumiraDx NT-proBNP test is a rapid microfluidic immunofluorescence assay for the quantitative measurement of NT-proBNP in human capillary, venous whole blood and plasma specimens. Inventive Sparks, Expanding Markets The major companies present in the D-dimer test market are Bio/Data Corporation, Becton Dickinson BV, Sysmex Corporation, Abbott Laboratories, Inc., Dickinson and Company, Hoffman-La Roche Ltd., among others. Global companies work to foster lasting innovation, grow their markets, and provide quality goods and services. They concentrate on improving customer experience, applying tech, and creating strong operations. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS


Boston Globe
8 hours ago
- Boston Globe
Judge orders liquidation of Infowars to pay Sandy Hook families
Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up AVIATION Advertisement Startup Merlin Labs valued at $800 million in deal to go public Merlin Labs wants to test its autonomous aviation software at Hanscom. Photo courtesy of Merlin Labs Autonomous aviation startup Merlin Labs will soon be soaring into the public markets now that it has signed a deal to merge with a blank-check company early next year. The terms of the deal, with a special purpose acquisition company managed by New York-based Inflection Point, values Boston-based Merlin at $800 million, prior to the results of a follow-on private purchase of shares. Merlin chief executive Matt George says the money raised by going public will help Merlin add more employees to its 170-person workforce and also provide capital for future acquisitions. Merlin is working on tech that will allow commercial and military planes to be flown with only one pilot, and eventually without one at all. George said the firm is close to signing a lease to take over much of a former Navy hangar in Bedford at Hanscom Field, once used to house a corporate jet fleet for defense contractor Raytheon (now RTX). Merlin could eventually employ as many as 200 people there. Last year, the company landed a $105 million contract with the Department of Defense to integrate Merlin Pilot software into the C-130J airlifter manufactured by Lockheed Martin. Inflection Point chief executive Mike Blitzer will join the Merlin board as a result of the upcoming deal; Inflection Point's recent successes include two other companies launched through similar SPAC deals, USA Rare Earth (current market cap of $1.7 billion) and Intuitive Machines (worth $1.6 billion today). — JON CHESTO Advertisement HEALTH CARE Costco will not sell abortion pills after pressure from conservatives A Costco Wholesale store in Everett. Jonathan Wiggs/Globe Staff/Boston Globe Costco will not dispense a key abortion pill at its pharmacies, a long-awaited win for conservatives trying to limit access to medication abortion. For more than a year, Costco deliberated over whether to become certified to dispense mifepristone, the drug used first in the typical two-step regimen for a medication abortion. The procedure, often easier and cheaper than the surgical alternative, is the option women in America most frequently choose to end pregnancies. Costco received pressure from groups on both sides of the issue, many of them investors in the nationwide grocery giant. The company's decision not to sell the pill, first reported by Bloomberg, is a victory for antiabortion advocates — but a narrow one. Despite lawsuits and letters pleading to lawmakers, their campaign to thwart access to abortion pills has otherwise been slow-moving. Patients can still access medication abortion in all 50 states, even those where the procedure is illegal, because of laws allowing the pills to be remotely prescribed and mailed. In a statement Thursday, Costco said the decision was 'based on the lack of demand from our members and other patients.' The company did not answer further questions from The Washington Post about the influence of outside groups. — WASHINGTON POST Advertisement SPORTS LA Olympics to sell naming rights to some venues in game-changing deal for 2028 Organizers of the Los Angeles Olympics will sell naming rights for a handful of its venues in deals expected to bring multiple millions of dollars to the 2028 Games while breaking down the International Olympic Committee's long-sacrosanct policy of keeping brand names off its arenas and stadiums. The organizing committee announced the landmark deal Thursday, saying contracts were already in place with two of its founding partners — Honda, which already has naming rights for the arena in Anaheim that will host volleyball, and Comcast, which will have its name on the temporary venue hosting squash. LA28 chairman and CEO Casey Wasserman said revenue from the deals goes above what's in LA's current $6.9 billion budget. He portrayed the deal as the sort of paradigm-shifting arrangement that Los Angeles needs more than other host cities because, as is typical for American-hosted Olympics, the core cost of these games aren't backed by government funding. — ASSOCIATED PRESS HOUSING Average rate on a 30-year mortgage drops to lowest level since October A "for sale" sign displayed in front of a single-family home on July 17, 2025, in Derry, N.H. Charles Krupa/Associated Press The average rate on a 30-year US mortgage fell this week to its lowest level in nearly 10 months, giving prospective homebuyers a sorely needed boost in purchasing power that could help inject life into a stagnant housing market. The long-term rate fell to 6.58 percent from 6.63 percent last week, mortgage buyer Freddie Mac said Thursday. A year ago, the rate averaged 6.49 percent. Borrowing costs on 15-year fixed-rate mortgages, popular with homeowners refinancing their home loans, also fell. The average rate dropped to 5.71 percent from 5.75 percent last week. A year ago, it was 5.66 percent, Freddie Mac said. Elevated mortgage rates have helped keep the US housing market in a sales slump since early 2022, when rates started to climb from the rock-bottom lows they reached during the pandemic. Home sales sank last year to their lowest level in nearly 30 years. This is the fourth week in a row that rates have come down. The latest average rate on a 30-year mortgage is now at its lowest level since Oct. 24, when it averaged 6.54 percent. — ASSOCIATED PRESS Advertisement PHILANTHROPY Nike cofounder Phil Knight and wife give record $2 billion to Oregon cancer center, university says In this Sept. 26, 2015, file photo, Nike cofounder Phil Knight watched from the sidelines during the second half of an NCAA college football game between Oregon and Utah in Eugene, Ore. Ryan Kang/Associated Press Nike cofounder Phil Knight and his wife Penny Knight have pledged to donate $2 billion to Oregon Health & Science University's Knight Cancer Institute, the university announced Thursday, describing it as a record-breaking gift. 'This gift is an unprecedented investment in the millions of lives burdened with cancer, especially patients and families here in Oregon,' OHSU President Shereef Elnahal said in a statement. The donation will help ensure patients have access to various resources, including psychological, genetic, and financial counseling, symptom management, nutritional support and survivorship care, the university statement said. The university described it as the 'largest single donation ever made to a US university, college or academic health center.' It surpasses the $1.8 billion given by Michael Bloomberg to Johns Hopkins in 2018, described by that university at the time as the largest single contribution to a US university. Bloomberg also donated an additional $1 billion to Johns Hopkins last year, covering tuition, living expenses, and fees for students from families under certain income levels. — ASSOCIATED PRESS Advertisement CONSUMER SAFETY Werner recalls more than 100,000 ladders due to potential fall and injury hazard Werner on Thursday said it is recalling more than 100,000 faulty ladders due to a locking mechanism that can fail, potentially causing users to fall and injure themselves. In cooperation with federal consumer product regulators, Werner is recalling 122,250 Multi-Max Pro ladders that come in 20-foot and 24-foot sizes. The ladders were sold exclusively at Home Depot between November of 2021 and February of 2024 with prices between $200 and $281. The Illinois-based company said owners of the ladders being recalled should stop using them immediately and register at to begin the process for a full refund. Once owners have properly disposed of their ladders per Werner's instructions, the company said it will issue a check for a full refund. The ladders are silver with a blue top and a blue label on the side rail with an oval containing the word 'Werner' and 'MULTI MAX PRO.' The size and model numbers are ALMP-20IAA or ALMP-24IAA and have a long black rope in the back. Werner said it has received 18 reports of falls, including 14 reports of injuries resulting in bruising, lacerations, head injuries, and fractures to the wrist, leg, and ribs. — ASSOCIATED PRESS